Inventors: KVG Chandra Sekhar, Murugesn S

This paper focuses on the discovery and biological evaluation of novel dual inhibitors targeting both DprE1 and InhA as potential anti-tubercular agents. DprE1 and InhA are key enzymes in the biosynthesis of mycolic acids, essential components of the Mycobacterium tuberculosis cell wall. The study involves identifying new compounds.